Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis
Jonathan M. Spergel(University of Pennsylvania), Eilish McCann(Regeneron (United States)), Sarette T. Tilton(Sanofi (United States)), Lila Glotfelty(Icahn School of Medicine at Mount Sinai), Arsalan Shabbir(Regeneron (United States)), Xian Sun(Regeneron (United States)), Evan S. Dellon(University of North Carolina at Chapel Hill), Mirna Chehade(Icahn School of Medicine at Mount Sinai), Albert J. Bredenoord(Amsterdam Neuroscience)
Cited by 12
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
|Gastroenterology|2015|996